Holdings of PHARMACEUTICALS ULTRASECTOR PROFUND
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 8.6M $ including 6.1M $ in equities, 70.6 %
- Positions
- 64 in 3 countries
- Top ten
- 18.1 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Crinetics Pharmaceuticals Inc | 2,675 | 223.4K $ | 2.60 % |
| 2 | MBX BIOSCIENCES INC | 2,963 | 195.4K $ | 2.28 % |
| 3 | AtaiBeckley Inc | 24,288 | 174.4K $ | 2.03 % |
| 4 | Definium Therapeutics Inc | 3,950 | 171.9K $ | 2.00 % |
| 5 | AMYLYX PHARMACEUTICALS INC | 6,821 | 138.5K $ | 1.62 % |
| 6 | Enliven Therapeutics Inc | 2,481 | 136K $ | 1.59 % |
| 7 | Corcept Therapeutics Inc | 1,175 | 134.5K $ | 1.57 % |
| 8 | ALUMIS INC | 4,577 | 129.3K $ | 1.51 % |
| 9 | Nuvation Bio Inc | 20,045 | 126.9K $ | 1.48 % |
| 10 | Trevi Therapeutics Inc | 6,851 | 125K $ | 1.46 % |
| 11 | Liquidia Corp | 1,407 | 118.3K $ | 1.38 % |
| 12 | Nektar Therapeutics | 1,617 | 114.3K $ | 1.33 % |
| 13 | Amneal Pharmaceuticals Inc | 5,993 | 109.8K $ | 1.28 % |
| 14 | Bristol-Myers Squibb Co | 1,651 | 107.8K $ | 1.26 % |
| 15 | Edgewise Therapeutics Inc | 2,789 | 107.2K $ | 1.25 % |
| 16 | OMEROS CORP | 9,001 | 106.6K $ | 1.24 % |
| 17 | Ligand Pharmaceuticals Inc | 370 | 106.4K $ | 1.24 % |
| 18 | ELANCO ANIMAL HEALTH INC | 4,014 | 105.8K $ | 1.23 % |
| 19 | VERADERMICS INC | 987 | 103.6K $ | 1.21 % |
| 20 | Pacira BioSciences Inc | 3,920 | 103.5K $ | 1.21 % |
| 21 | VIATRIS INC | 5,822 | 102.2K $ | 1.19 % |
| 22 | JAZZ PHARMACEUTICALS PLC | 400 | 101.1K $ | 1.18 % |
| 23 | Eton Pharmaceuticals Inc | 2,169 | 100.7K $ | 1.17 % |
| 24 | Maze Therapeutics Inc | 3,733 | 100.5K $ | 1.17 % |
| 25 | Merck & Co Inc | 771 | 100.4K $ | 1.17 % |
| 26 | Harrow Inc | 2,557 | 99.1K $ | 1.16 % |
| 27 | Johnson & Johnson | 385 | 98.7K $ | 1.15 % |
| 28 | ROYALTY PHARMA PLC | 1,684 | 98.4K $ | 1.15 % |
| 29 | Indivior Pharmaceuticals Inc | 2,410 | 96.4K $ | 1.12 % |
| 30 | Prestige Consumer Healthcare Inc | 1,869 | 93.9K $ | 1.09 % |
| 31 | Collegium Pharmaceutical Inc | 2,638 | 93.4K $ | 1.09 % |
| 32 | Eli Lilly & Co | 81 | 93.1K $ | 1.09 % |
| 33 | Organon & Co | 6,862 | 93K $ | 1.08 % |
| 34 | EyePoint Inc | 7,446 | 91.2K $ | 1.06 % |
| 35 | Harmony Biosciences Holdings Inc | 2,588 | 91.2K $ | 1.06 % |
| 36 | Supernus Pharmaceuticals Inc | 2,036 | 90.9K $ | 1.06 % |
| 37 | Pfizer Inc | 3,586 | 89.7K $ | 1.05 % |
| 38 | WAVE LIFE SCIENCES LTD | 16,221 | 89.4K $ | 1.04 % |
| 39 | Phibro Animal Health Corp | 2,460 | 89.4K $ | 1.04 % |
| 40 | ANI Pharmaceuticals Inc | 1,122 | 88.9K $ | 1.04 % |
| 41 | TARSUS PHARMACEUTICALS INC | 1,498 | 88.4K $ | 1.03 % |
| 42 | Zoetis Inc | 1,129 | 87.3K $ | 1.02 % |
| 43 | OCULAR THERAPEUTIX INC | 10,504 | 85.8K $ | 1.00 % |
| 44 | Xeris Biopharma Holdings Inc | 10,572 | 85.4K $ | 1.00 % |
| 45 | Rapport Therapeutics Inc | 2,076 | 85.1K $ | 0.99 % |
| 46 | Innoviva Inc | 3,992 | 83.7K $ | 0.98 % |
| 47 | Perrigo Co PLC | 8,219 | 83.1K $ | 0.97 % |
| 48 | Axsome Therapeutics Inc | 373 | 81.3K $ | 0.95 % |
| 49 | Amphastar Pharmaceuticals Inc | 3,730 | 74.4K $ | 0.87 % |
| 50 | Arvinas Inc | 9,028 | 72.5K $ | 0.85 % |
| 51 | Alto Neuroscience Inc | 2,671 | 72.3K $ | 0.84 % |
| 52 | Septerna Inc | 1,779 | 61.3K $ | 0.71 % |
| 53 | LB Pharmaceuticals Inc | 1,477 | 59.2K $ | 0.69 % |
| 54 | CorMedix Inc | 7,721 | 58.1K $ | 0.68 % |
| 55 | Theravance Biopharma Inc | 3,386 | 57.1K $ | 0.67 % |
| 56 | Aclaris Therapeutics Inc | 10,166 | 52.9K $ | 0.62 % |
| 57 | Phathom Pharmaceuticals Inc | 5,895 | 51.6K $ | 0.60 % |
| 58 | Zevra Therapeutics Inc | 5,187 | 49.3K $ | 0.58 % |
| 59 | Relmada Therapeutics Inc | 9,199 | 48.8K $ | 0.57 % |
| 60 | Aquestive Therapeutics Inc | 11,061 | 40.9K $ | 0.48 % |
| 61 | FULCRUM THERAPEUTICS INC | 11,341 | 40.6K $ | 0.47 % |
| 62 | LEXICON PHARMACEUTICALS INC | 15,756 | 36.4K $ | 0.42 % |
| 63 | BioAge Labs Inc | 3,681 | 33.3K $ | 0.39 % |
| 64 | Evolus Inc | 4,569 | 26.7K $ | 0.31 % |
Sector breakdown
- Health care 13.0 %
- Unattributed 87.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 95.5 %
- Ireland 3.0 %
- Singapore 1.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 61 | 5.8M $ | 95.48 % |
| 2 | Ireland | 2 | 184.2K $ | 3.04 % |
| 3 | Singapore | 1 | 89.4K $ | 1.48 % |
Cite this page
Titelia. "Holdings of PHARMACEUTICALS ULTRASECTOR PROFUND". https://titelia.com/en/funds/S000003093